BERK, V. Et Al. 2015. Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab. Asian Pacific Journal Of Cancer Prevention , vol.16, no.14 , 6149-6154.

BERK, V., DENİZ, K., BOZKURT, O., ÖZASLAN, E., KARACA, H., İNANÇ, M., ... OCAK DURAN, A.(2015). Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab. Asian Pacific Journal Of Cancer Prevention , vol.16, no.14, 6149-6154.

BERK, Veli Et Al. "Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab," Asian Pacific Journal Of Cancer Prevention , vol.16, no.14, 6149-6154, 2015

BERK, Veli Et Al. "Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab." Asian Pacific Journal Of Cancer Prevention , vol.16, no.14, pp.6149-6154, 2015

BERK, V. Et Al. (2015) . "Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab." Asian Pacific Journal Of Cancer Prevention , vol.16, no.14, pp.6149-6154.

@article{article, author={Veli BERK Et Al. }, title={Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab}, journal={Asian Pacific Journal Of Cancer Prevention}, year=2015, pages={6149-6154} }